Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

236.72
+5.552.40%
Pre-market: 236.720.00000.00%04:00 EDT
Volume:3K
Turnover:756.09K
Market Cap:474.98M
PE:- -
High:236.72
Open:236.01
Low:235.52
Close:231.17
52wk High:244.35
52wk Low:160.91
Shares:2.01M
Float Shares:2.01M
Volume Ratio:0.74
T/O Rate:0.16%
Dividend:0.95
Dividend Rate:0.40%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS
·
Sep 15

Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean

Reuters
·
Sep 15

Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access

THOMSON REUTERS
·
Sep 15

Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call

THOMSON REUTERS
·
Sep 15

Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call

THOMSON REUTERS
·
Sep 15

Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17

Reuters
·
Sep 15

Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness

TIPRANKS
·
Sep 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Sep 15

Amgen to deploy Veeva Vault CRM globally

TIPRANKS
·
Sep 15

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Dow Jones
·
Sep 15

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)

TIPRANKS
·
Sep 15

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 15

Revolution Medicines Gets US FDA Breakthrough Therapy Designation for Rasonque To Treat Pancreatic Cancer

MT Newswires Live
·
Sep 15

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 15

Revolution Medicines granted Breakthrough Therapy Designation to Rasonque by FDA

TIPRANKS
·
Sep 15

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for Rasonque™ (Daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

THOMSON REUTERS
·
Sep 15

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

TIPRANKS
·
Sep 15

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Dow Jones
·
Sep 14

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Reuters
·
Sep 14

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS
·
Sep 14